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Abstract Our previous study showed that 1H-magnetic res-
onance spectroscopy (1H-MRS) can detect lipid peaks char-
acteristic forMycobacterium tuberculosis infection in cerebral
lesions of young children; therefore, we aimed to extend and
validate the application of 1H-MRS for the diagnosis of active
pulmonary tuberculosis lesions in three adolescent patients.
Here, we document lipid peaks characteristic forM. tuberculo-
sis infection by 1H-MRS from lung tissue surrounding lung
cavities of two patients whose sputum samples were positive
for acid-fast bacilli by microscopy and positive for M. tuber-
culosis by genetic testing, indicating active tuberculosis. A
similar lipid peak was found also in the pleural effusion of a
third patient with concurrent lung cavity compatible with active
tuberculosis. However, in a patient with a pyogenic pulmonary
abscess, 1H-MRS of the drained pus displayed different char-
acteristic peaks but no lipid peak at all. Conclusion: Our find-
ings further validate 1H-MRS as a rapid, non-invasive, and
specific diagnostic tool for active tuberculosis in children with
microbiologically documented infection outside the central
nervous system, specifically in the lungs.
Keywords Pulmonary lesions . Diagnosis . Magnetic
resonance imaging . Lipid . 1H-magnetic resonance
spectroscopy . Tuberculosis . Resource-poor country
Abbreviations
MRI Magnetic resonance imaging
1H-MRS 1H magnetic resonance spectroscopy
CT Computerized tomography
TB Tuberculosis
Introduction
The diagnosis of tuberculosis (TB) in children is hindered
compared to in adults for several reasons; these include
mainly atypical clinical presentation, unspecific signs on
imaging, and incapability to expectorate sputum for analysis
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[2, 6, 9]. Therefore, tuberculin skin testing to detect delayed-
type hypersensitivity or in vitro assays to detect interferon-γ
release by immune cells are often used as diagnostic tools to
get indirect evidence of infection with the causative agent
Mycobacterium tuberculosis. Nevertheless, the results of
both tests do not allow clear-cut distinction between active
and latent infection [7].
We have recently reported on the use of 1H-magnetic
resonance spectroscopy (1H-MRS) to detect lipid peaks char-
acteristic for cerebralM. tuberculosis infection manifesting as
tuberculoma in young children [8]. The 1H-MRS findings in
vivo and in vitro were quite similar in children in whom
aspiration of lesion material was feasible, and tuberculoma
uniformly exhibited elevated lipid peaks by 1H-MRS and
antituberculous treatment led to size reduction of the cerebral
lesions exhibiting lipid peaks [8]; our findings suggested that
1H-MRS may help to discriminate between various active
infectious etiologies [8]. However, the application of 1H-
MRS to forms of TB in children other than cerebral tuber-
culoma has not yet been reported.
The aim of the present study was to extend and validate
the application of 1H-MRS for the diagnosis of active pul-
monary TB lesions. For this reason, we performed 1H-MRS
in three adolescent patients with chest X-ray and CT find-
ings suggestive for TB and compared them to those from a
patient with a pyogenic lung abscess. All patients presented
with lung cavities and the third with an additional contra-
lateral pleural effusion. Sputum from the first two patients
could be sampled for microbiological and molecular inves-
tigation. Our results further support the uniqueness of 1H-
MRS to establish unambiguously the diagnosis of active M.
tuberculosis infection by non-invasive means.
Patients and methods
Patients The patients reported herein were hospitalized at
Jayavarman VII, Siem Reap, one of the five Kantha Bopha
children’s hospitals in Cambodia, because of severe illness
requiring inpatient care. Chest MRI and single voxel 1H-MRS
were done to investigate the reason for the marked respiratory
impairment and the cause of the pathological chest X-ray and
CT findings suggesting TB. A fourth patient with a pyogenic
lung abscess was included for comparison.
Magnetic resonance imaging (MRI) and 1H-magnetic reso-
nance spectroscopy (1H-MRS) In brief, imaging was per-
formed on a standard 3T MR Unit (Philips Achieva 3-T,
Best, the Netherlands) using an eight-channel phased-array
body coil. Conventional imaging included multiplanar T1-
and T2-weighted sequences as well as contrast-enhanced
T1-weighted sequences of the lung covering the thorax down
to the lower edge of the diaphragm. MRI was performed in Ta
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free breathing without respiratory gating (acquisitions in axial,
sagittal, and coronal plans). These sequences were done for
the evaluation of anatomical lesions. Single voxel 1H-MRS
was performed using a point resolved excitation selective
spectroscopy sequence (PRESS) prior to the contrast-
enhanced sequence using the standard departmental sequen-
ces as recently published [8]. Specifically, the imaging param-
eters were repetition time (TR)02,000 and echo time (TE)0
35 ms or 144 ms in order to differentiate lipid peaks (0.9–
1.3 ppm) from the overlapping lactate peak (1.3 ppm), respec-
tively. The number of acquisitions was 128 resulting in an
effective 1H-MRS acquisition time of 4 to 5 min. The voxel
was positioned within the lesion of interest. To avoid potential
respiratory motion artifacts and inclusion of lesions located
too peripherally, the patient had to stay still in a quiet breathing
condition during a timed acquisition. The voxel was manually
positioned within the lesion or the pleural fluid, and its size
was optimized for the size of the lesion or the pleural effusion.
In lesions with air–fluid level, the volume of interest (VOI)
was mandatorily located in the full-fluid collection of the
cavity, thus avoiding air–fluid-related artifact that could dis-
turb 1H-MRS spectra. The acquired data were postprocessed
using the vendor-specific software. The metabolites were dis-
played along the typical resonance frequency axis at which the
typical lipid peaks appear at 0.9–1.3 ppm. In addition, in vitro
1H-MRS was performed of the aspirated pus as described
recently [8].
Laboratory investigations Blood counts, chemistry, bacteri-
al cultures, and species identification, as well as human
immunodeficiency virus (HIV) serology, were done using
routine hospital procedures and methods.
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Fig. 1 Case 1: Axial T2 (a) and
axial contrast-enhanced T1-
weighted (b) MR images reveal
a large pulmonary cavern in the
right posterior upper lobe (white
arrow). 1H-MRS (e) of the up-
per lobe consolidation cranial to
the cavern shows a broad lipid
(Lip) peak at 0.9–1.3 ppm. The
rhombus symbols indicate the
voxel position of the 1H-MRS
(c, d)
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Molecular detection of M. tuberculosis Nucleic acid of M.
tuberculosis in sputum was detected using GenExpert (Ce-
pheid, Sunnyvale, CA, USA) according to the instructions of
the manufacturer. This test detects also rifampicin resistance
that is a surrogate for multi-drug resistance.
Clinical assessment The clinical status was evaluated in all
patients prior, during, and after treatment.
Results
A synopsis of the demographic, clinical, imaging, spectro-
scopic, and laboratory findings as well as the course of the
patients reported here is given in Table 1. The patients were
13 to 15 years old, and their histories of acute illness were
characterized by fever, cough, dyspnea, hemoptysis, or
weight loss and had lasted 7 to 90 days. Three patients
showed signs of cavern formation in the upper right lung
lobe, and one of them presented in addition with a left-sided
pleural effusion. One patient had leukocytosis (>15 G/l), all
patients had thrombocytosis (>500 G/l), and all were HIV
negative.
The two older patients with cavities were able to expec-
torate, and sputum from both was negative for bacteria on
Gram staining and bacterial cultures, but was positive for
acid-fast bacilli and for molecular detection of M. tubercu-
losis using GenExpert (Table 1; cases 1 and 2) that further
excluded rifampicin resistance. No sputum or pleural effu-
sion was obtained from the third patient (Table 1; case 3). In
these three patients, 1H-MRS revealed elevated lipid peaks
in the pulmonary consolidations surrounding the cavities
(case 1: Fig. 1 and case 2: Fig. 2) as well as in the pleural
fluid (case 3: Fig. 3). Notably, cases 1 and 2 presented well-
organized lesions as intra-parenchymal round cavities that
Lip
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Fig. 2 Case 2: Coronal (a),
sagittal (b) T2-weighted, and
axial T1-weighted (d) MR
images reveal a large pulmo-
nary cavern in the apex of the
right upper lobe within a large
consolidation (black arrow in a,
b). 1H-MRS (e) within the con-
solidation shows lipid (Lip)
peaks at 1.0 and 1.3 ppm, re-
spectively. The rhombus symbol
indicates the voxel position of
the 1H-MRS (c)
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were well separated from parahilar vessel structures that
could disturb 1H-MRS. Case 3 showed fluid collection in
the left pleural cavity with consolidation of the adjacent lung
parenchyma, and an air-cavern lesion in the right upper
lobe; in this case, 1H-MRS was not possible in the air-
filling cavity and consolidation area due to artifacts caused
by air and blood flow. Nevertheless, 1H-MRS was possible
in the left pleural effusion. In cases 1–3, by CT, there were
no detectable calcifications that could disturb 1H-MRS.
Treatment included isoniazid, rifampin, and pyrazinamide
for 6 months, ceftriaxone, and metronidazole for 10 days,
and steroids for 2 weeks, all medications in dosages adjusted
to age and weight. These three patients were discharged in
good conditions after 3–4 weeks, and follow-up for at least
two more months showed a favorable clinical course
(Table 1).
Case 4 showed an abscess in the lower left lobe. The
aspirated pus contained Gram-positive cocci that did not
grow in bacterial cultures, probably because of antibiotic
pretreatment. Furthermore, acid-fast staining and GenExpert
assay were negative. 1H-MRS ex vivo, as done previously
[8], showed acetate, succinate, lactate, and amino acid peaks
(Table 1; Fig. 4). Treatment with ceftriaxone and metroni-
dazole was terminated after 23 days, and the patient was
discharged after 3 weeks in good conditions.
Discussion
While 1H-MRS allows to identify brain tuberculoma non-
invasively with high specificity [8], we set out to apply and
validate this technique also for the diagnosis of active
ba c
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Lip
Fig. 3 Case 3: Coronal T1 (a), axial (b), and coronal (c) T2-weighted
images show a cavern in the right lung (white arrow in b) and the
atelectatic left lung and large pleural effusion on the left (black arrow).
1H-MRS of the effusion (d) shows a broad lipid (Lip) peak at 0.9–
1.3 ppm. Note the residual water peak at 4.0–4.2 ppm due to poor
shimming. The rhombus symbols indicate the position of the voxels of
the 1H-MRS (black arrow)
Eur J Pediatr (2012) 171:1257–1263 1261
pulmonary TB lesions. We found lipid peaks characteristic
for active M. tuberculosis infection in 1H-MRS [3, 4, 8] in
three patients with suspected TB: in two patients with lung
cavities whose sputum samples were positive for acid-fast
bacilli and for genetic testing of M. tuberculosis and in one
patient with a pleural effusion. Hence, we show 1H-MRS
lipid peaks in children with microbiologically established
TB and thus further validate 1H-MRS as a specific non-
invasive diagnostic tool for active TB in children.
1H-MRSwithin the chest is challenging because of moving
lung, pulsating vessel structures, and air. To avoid artifacts
caused by neighboring air or vascular structures, the voxel
must be positioned in a well-defined fluid collection. 1H-MRS
may be less affected by respiration-related motion in the upper
pulmonary lobes where TB preferentially localizes. If multiple
lesions are present, the voxel should be set in the largest solid
lesion and not within an air-filled cavity. Since we allowed the
patients to breath during acquisition time, the spectrum could
be undetermined or not interpretable; in such case, the acqui-
sition was repeated to obtain unequivocal data. Thus, careful
positioning of the voxel and immediate quality assessment of
the spectrum obtained are crucial.
The clear-cut lipid peaks visualized by 1H-MRS in three
adolescents presenting with lung cavity formation were
striking. Subsequent detection of acid-fast bacilli and the
genetic identification of M. tuberculosis in sputum of two of
the patients allowed to firmly establish the diagnosis of
active TB and robustly validated the diagnostic value of
the lipid peaks detected in the lungs. Notably, 1H-MRS in
the three patients did not show any of the additional acetate,
succinate, lactate, or amino acid peaks. This suggested that
conventional bacteria were not involved in the lung abscess-
es [3, 8], and indeed, staining and culture of sputum for
conventional bacteria were negative. Undeniably, pyogenic
lung abscess as confirmed by Gram staining lacked the lipid
peak but showed acetate, succinate, lactate, and amino acid
peaks, strikingly contrasting our observation in the three other
patients. Thus, 1H-MRS seems to be a rather specific diag-
nostic tool to differentiate lung lesions due toM. tuberculosis
from those caused by pyogenic bacteria.
The demonstration of a lipid peak in 1H-MRS of pleural
effusion in case 3, being very similar to those detected in
pulmonary consolidations surrounding microbiologically
and genetically confirmed tuberculous lung lesions in cases
1 and 2, is remarkable. The absence of peaks other than the
lipid peak in 1H-MRS again argues against conventional
bacteria being the cause of the pleural effusion [5]. More-
over, the contralateral cavity formation in the lung was
suggestive of active TB [5, 6]. Therefore, in view of the
favorable course in the patient subsequent to antituberculous
treatment, active TB seems very likely. Thus, it is tempting
to speculate that 1H-MRS may be useful to diagnose active
TB even in pleural effusion.
Our report has the limitation that cases 1–3 received
ceftriaxone and metronidazole together with the antituber-
culous regimen in the initial 10 days of treatment. Both
antimicrobials are active against conventional bacteria that
may cause lung or pleural pathology, and they were pre-
scribed empirically since no data on the specificity of 1H-
MRS from lungs were available so far. Thus, the favorable
responses of the patients to the installed antimicrobial treat-
ment could also be due to the action of ceftriaxone or
metronidazole, or both. The negative staining and cultures for
conventional bacteria and the absence of acetate, succinate,
lactate, and/or amino acid peaks in 1H-MRS, however, make
this unlikely [5].
In summary, 1H-MRS was validated for the non-invasive
establishing the diagnosis of active TB in microbiologically
confirmed tuberculous lung cavity lesions and provides also a
powerful, rapid, specific, and sensitive tool to diagnose TB
a
b
Ac
Suc
Lac/Lip Aa
Fig. 4 Case 4: Axial CT (a) showing an abscess in the lower left lobe.
1H-MRS of the aspirated pus (b) shows large acetate (Ac) and succinate
(Suc) peaks as well as small lactate/lipid (Lac/Lip) and amino acid (Aa)
peaks. The spectrum was taken at TE 144 ms as opposed to TE 35 ms
used for spectra in Figs. 1, 2, and 3. Rhombus symbols show the voxel
position of the 1H-MRS
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manifesting pleural effusion. Importantly, 1H-MRS must be
considered in the close context of clinical and imaging find-
ings [2] since lipid peaksmay not be entirely specific for TB in
conditions including tissue necrosis [1]. Albeit 1H-MRS may
be regarded as a method to be reserved for high-technology
medical facilities in wealthy countries, our report evidences
that it may provide an excellent, non-invasive tool to improve
significantly medical care and cure of TB in areas where this is
of paramount importance.
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